Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 10, 2015 11:04 AM ET

Healthcare Equipment and Supplies

Company Overview of Metamark Genetics, Inc.

Company Overview

Metamark Genetics, Inc. develops diagnostic and prognostic tests for urology cancer care. It offers ProMark, a protein based prognostic test for prostate cancer; and Progensa, a urine-based molecular test to make informed repeat biopsy decisions. The company also provides cytology diagnostic services for diagnosis of bladder cancer; luorescence in situ hybridization, a diagnostic tool that helps to confirm patient’s cytology results; histology diagnostic services for prostate and bladder biopsy analysis and examinations; and PTEN/ERG molecular testing that predicts aggressiveness of HGPIN/atypical or low gleason score. It offers services in the areas of diagnosis and management of prostate c...

245 First Street

10th Floor

Cambridge, MA 02142

United States

Founded in 2007





Key Executives for Metamark Genetics, Inc.

Co-Founder, Chairman, Chief Executive Officer and President
Age: 77
Co-Founder, Director and Scientific & Clinical Advisor
Age: 72
Co-Founder and Scientific & Clinical Advisor
Chief Science Officer and Senior Vice President
Chief Medical Officer
Compensation as of Fiscal Year 2015.

Metamark Genetics, Inc. Key Developments

Metamark Genetics Names Peter Maimonis as Senior Vice President and Chief Science Officer

Metamark Genetics, Inc. announced that Peter Maimonis, Ph.D., has joined Metamark's leadership team as Senior Vice President and Chief Science Officer, effective October 7, 2015. Dr. Maimonis brings extensive experience in oncology research and development, and specific proficiency in oncology biomarkers in the area of prostate cancer. He has presented at a large number of national and international scientific conferences, and published many peer-reviewed articles and abstracts on cancer biomarkers. Dr. Maimonis has held senior level positions in various areas of research and development at Ciba-Corning, Chiron Diagnostics, Bayer Diagnostics, Decision Biomarkers, and On-Q-ity, and most recently served as Vice President of Biomarker Development at Biothera, working with their novel cancer immunotherapeutic.

Metamark Genetics, Inc Announces Management Changes

Metamark Genetics, Inc. announced that Kenneth E. Weg has been named as the company's new President and Chief Executive Officer, and continues as Chairman of the Board of Directors of Metamark. Mr. Weg succeeds Shawn Marcell, who resigned from his position to pursue other activities. Mr. Weg has more than thirty years of experience and previously served as the President of the Worldwide Medicines Group at Bristol-Myers Squibb (BMS).

Metamark Appoints Jerome Richie as Chief Medical Officer, Effective July 1, 2015

Metamark has appointed Dr. Jerome Richie as its chief medical officer. Richie will join the leadership team effective July 1, retiring from his current role of chief emeritus of Harvard program in Urology at Brigham and Women's Hospital and a surgery professor at Harvard Medical School.

Similar Private Companies By Industry

Company Name Region
Lazarus Effect, Inc. United States
Qardio, Inc. United States
TheraB Medical Products, Inc. United States
CardiAQ Valve Technologies, Inc. United States
Luzerne Optical Laboratories, Ltd. United States

Recent Private Companies Transactions

Private Placement
September 10, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Metamark Genetics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at